Ameritas Investment Partners, Inc. Natera, Inc. Transaction History

Ameritas Investment Partners, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$86.05 - $119.72 $537,210 - $747,411	-6,243 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $8,506 - $11,565	-93 Reduced 1.47%	6,243 $634,000
Q4 2020 Feb 12, 2021	BUY	$66.66 - $111.74 $11,598 - $19,442	174 Added 2.82%	6,336 $631,000
Q2 2020 Aug 05, 2020	BUY	$26.36 - $49.86 $14,761 - $27,921	560 Added 10.0%	6,162 $307,000
Q1 2020 May 13, 2020	BUY	$17.27 - $40.17 $4,231 - $9,841	245 Added 4.57%	5,602 $167,000

Q4 2019 Feb 13, 2020	BUY	$32.1 - $40.4 $16,948 - $21,331	528 Added 10.93%	5,357 $180,000
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $38,109 - $59,214	2,147 Added 80.05%	4,829 $133,000
Q4 2017 Feb 14, 2018	BUY	$8.99 - $14.31 $5,843 - $9,301	650 Added 31.99%	2,682 $24,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,032	2,032 $22,000

439

117M

254K

263K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $10.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.